We are live on ! Find out more
FPC

Falcon Point Capital Portfolio holdings

AUM $11.9M
1-Year Est. Return 55.76%
This Fund
S&P 500
This Quarter Est. Return
+8.77%
1 Year Est. Return
+55.76%
3 Year Est. Return
+118.89%
5 Year Est. Return
+197.9%
10 Year Est. Return
AUM
$466M
AUM Growth
-$43.6M
Cap. Flow
-$69.9M
Cap. Flow %
-15.02%
Top 10 Hldgs %
29.63%
Holding
125
New
8
Increased
24
Reduced
67
Closed
15

Top Sells

Rank Stock Value
1
RAMP icon
LiveRamp
RAMP
+$11.5M
2
AMAG
AMAG Pharmaceuticals
AMAG
+$10.4M
3
FIVN icon
FIVE9
FIVN
+$7.27M
4
USCR
U S Concrete, Inc.
USCR
+$6.87M
5
NEO icon
NeoGenomics
NEO
+$6.48M

Sector Composition

Rank Sector Weight
1 Industrials 21.99%
2 Healthcare 19.44%
3 Technology 15.63%
4 Consumer Discretionary 13.45%
5 Consumer Staples 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLG.PRU
76
Flagstar Bank National Association Bifurcated Option Note Unit Securities
FLG.PRU
$119M
$494K 0.11%
10,000
-25,000
-71% -$1.24M
TANNL
77
DELISTED
TRAVEL CENTERS OF AMERICA LLC 8.00% SENIOR NOTES DUE 2029
TANNL
$493K 0.11%
20,000
-75,000
-79% -$1.81M
HCKT icon
78
Hackett Group
HCKT
$266M
$434K 0.09%
+21,524
New +$401K
ALDX icon
79
Aldeyra Therapeutics
ALDX
$95.3M
$397K 0.09%
28,772
-5,197
-15% -$42.2K
PFNX
80
DELISTED
Pfenex Inc.
PFNX
$397K 0.09%
77,615
-5,628
-7% -$28.9K
GPX
81
DELISTED
GP Strategies Corp.
GPX
$382K 0.08%
22,668
-1,645
-7% -$30.3K
NERV icon
82
Minerva Neurosciences
NERV
$199M
$351K 0.08%
3,492
+776
+29% +$58.3K
NEOS
83
DELISTED
Neos Therapeutics, Inc
NEOS
$350K 0.08%
72,201
-270,420
-79% -$1.53M
RNG icon
84
RingCentral
RNG
$4.77B
$328K 0.07%
3,523
-556
-14% -$48K
ACRS icon
85
Aclaris Therapeutics
ACRS
$744M
$275K 0.06%
18,965
+3,921
+26% +$67.2K
PETQ
86
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$273K 0.06%
+6,934
New +$231K
SJB icon
87
ProShares Short High Yield
SJB
$51.7M
$265K 0.06%
11,753
-56,507
-83% -$1.29M
MA icon
88
Mastercard
MA
$497B
$256K 0.06%
1,148
-88
-7% -$18.4K
APO.PRA
89
DELISTED
Apollo Global Management, Inc. 6.375% Series A Preferred Shares
APO.PRA
$252K 0.05%
10,000
-50,000
-83% -$1.27M
DVAX
90
DELISTED
Dynavax Technologies
DVAX
$248K 0.05%
+20,023
New +$271K
FLIR
91
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$242K 0.05%
+3,933
New +$232K
VRNS icon
92
Varonis Systems
VRNS
$5.13B
$241K 0.05%
9,882
-228
-2% -$5.54K
GHM icon
93
Graham Corp
GHM
$1.17B
$240K 0.05%
8,525
-617
-7% -$16.7K
V icon
94
Visa
V
$697B
$234K 0.05%
1,560
TRTN
95
DELISTED
Triton International Limited
TRTN
$218K 0.05%
6,540
-25,000
-79% -$881K
UBA
96
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$201K 0.04%
9,440
ESIO
97
DELISTED
Electro Scientific Industries
ESIO
$199K 0.04%
+11,391
New +$222K
CLSD
98
DELISTED
Clearside Biomedical
CLSD
$192K 0.04%
2,081
+1,102
+113% +$131K
CSLT
99
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$192K 0.04%
71,276
-39,039
-35% -$138K
SPCE icon
100
Virgin Galactic
SPCE
$320M
$153K 0.03%
771

Similar funds

Falcon Point Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Falcon Point Capital held 125 positions worth $466M, down 8.6% from $509M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Falcon Point Capital withdrew a net $69.9M in Q3 2018, closing 15 positions and reducing 67 holdings. Its most notable exit was U S Concrete, Inc., an estimated $6.87M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Falcon Point Capital opened a new position in Strategic Education worth $11.1M.

  • Falcon Point Capital's largest Q3 2018 buy was Strategic Education: 80,854 shares worth $11.1M.
  • Falcon Point Capital added most to Supernus Pharmaceuticals in Q3 2018, an estimated $5.58M increase.
  • Falcon Point Capital's biggest Q3 2018 reduction was LiveRamp, cutting an estimated $11.5M.
  • Falcon Point Capital fully exited U S Concrete, Inc. in Q3 2018, selling an estimated $6.87M.
  • Falcon Point Capital's ten largest holdings make up 30% of its $466M portfolio in Q3 2018.
  • Falcon Point Capital opened 8 new positions and closed 15 in Q3 2018.
  • Falcon Point Capital's portfolio value fell 8.6% quarter-over-quarter to $466M.

Based on Falcon Point Capital's 13F filing for Q3 2018, filed 6 Nov 2018.